Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Neuville

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Heliyon|April 9, 2025
Corrigendum to "Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatients" [Heliyon Volume 10, Issue 13, July 15, 2024, Article e33231]Quentin Philippot, Blandine Rammaert, Gaëlle Dauriat, et al.
Journal of Internal Medicine|November 24, 2025
Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profileValentine Pagis, Quentin Astouati, Lucas Pacoureau, et al.
Science Immunology|July 20, 2022
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNsPaul Bastard, Sara E Vazquez, Jamin Liu, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Heliyon|April 9, 2025
Corrigendum to "Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatients" [Heliyon Volume 10, Issue 13, July 15, 2024, Article e33231]Quentin Philippot, Blandine Rammaert, Gaëlle Dauriat, et al.
Journal of Internal Medicine|November 24, 2025
Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profileValentine Pagis, Quentin Astouati, Lucas Pacoureau, et al.
Science Immunology|July 20, 2022
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNsPaul Bastard, Sara E Vazquez, Jamin Liu, et al.
Pageof 5